Marksan Pharma
view: Positive for long term
Marksans Pharma is engaged in Business of Formulation of pharmaceutical products. It has built a steady franchise in the regulated market space of the UK and US (over 80% revenues), with a front-end presence through subsidiaries. Operating margins increased steadily due to an improvement in the portfolio mix, improved pricing scenario in the US market and the reducing Brexit-related uncertainties in the UK.